Concepedia

Publication | Open Access

Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase

DOIFull Paper Access

65

Citations

26

References

2007

Year

R. Kast, Hartmut Schirok, Santiago Figueroa‐Pérez, Joachim Mittendorf, Mark Jean Gnoth, Heiner Apeler, J Lenz, Jürgen K. Franz, Joachim Hütter, Mario Lobell,
British Journal of Pharmacology

Abstract

Azaindole 1 is representative of a new class of selective and potent ROCK inhibitors and is a valuable tool for the elucidation of the role of ROCK in the cardiovascular system.

References

YearCitations

Page 1